MADRIGAL PHARMACEUTICALS, INC. (MDGL) Form SCHEDULE 13D/A — Nov 6, 2026
Baker Bros. Advisors LP and related reporting persons (including Chairman Julian C. Baker and Felix J. Baker) filed Amendment No.
Key figures
- Shares Outstanding
- 23229561
- Purchase dates
- 2026-11-04 to 2026-11-06
- Percent of class
- 9.99%
- Prefunded warrants
- 2705790
- Purchase price range
- $366.77 - $396.61
- Series a convertible preferred
- 1969797
- Series b convertible preferred
- 400000
- Beneficial ownership limitation
- 4.99% (Series A/B), 9.99% max (Prefunded Warrants)
- Aggregate beneficial ownership shares
- 2330144
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.